Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies

Objective: The recent FDA approval of the first 7T MRI scanner for clinical diagnostic use in October 2017 will likely increase the utilization of 7T for epilepsy presurgical evaluation. This study aims at accessing the radiological and clinical value of 7T in patients with pharmacoresistant focal e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Z. Irene, Oh, Se-Hong, Lowe, Mark, Larvie, Mykol, Ruggieri, Paul, Hill, Virginia, Statsevych, Volodymyr, Moon, Doksu, Lee, Jonathan, Emch, Todd, Bena, James, Blümcke, Ingmar, Bingaman, William, Gonzalez-Martinez, Jorge A., Najm, Imad, Jones, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960771/
https://www.ncbi.nlm.nih.gov/pubmed/33737901
http://dx.doi.org/10.3389/fneur.2021.591586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960771/
https://www.ncbi.nlm.nih.gov/pubmed/33737901
http://dx.doi.org/10.3389/fneur.2021.591586

Ejemplares similares